Efficient agent degradation within skin is important for decontamination of percutaneously exposed VX

References

• Amend N, Niessen KV, Seeger T, et al. Diagnostics and treatment of nerve agent poisoning-current status and future developments. Ann NY Acad Sci. 2020;1479:13–28.
   PubMed Web of Science ®Google Scholar
• Chai PR, Boyer EW, Al-Nahhas H, et al. Toxic chemical weapons of assassination and warfare: nerve agents VX and sarin. Toxicol Commun. 2017;1:21–23.
   PubMedGoogle Scholar
• Yusof AN. Statement by H.E. ambassador Ahmad Nazri Yusof permanent representative of Malaysia to the OPCW at the ninetieth session of the executive council. Organisation for the Prohibition of Chemical Weapons; 2019.
   Google Scholar
• Genovese RF, Benton BJ, Oubre JL, et al. Determination of threshold adverse effect doses of percutaneous VX exposure in African green monkeys. Toxicology. 2011;279:65–72.
   PubMed Web of Science ®Google Scholar
• Mann TM, Price ME, Whitmore CL, et al. Bioscavenger is effective as a delayed therapeutic intervention following percutaneous VX poisoning in the guinea-pig. Toxicol Lett. 2018;293:198–206.
   PubMed Web of Science ®Google Scholar
• Reiter G, Müller S, Hill I, et al. In vitro and in vivo toxicological studies of V nerve agents: molecular and stereoselective aspects. Toxicol Lett 2015;232:438–448.
   PubMed Web of Science ®Google Scholar
• van der Schans MJ, Lander BJ, van der Wiel H, et al. Toxicokinetics of the nerve agent (+/−)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration. Toxicol Appl Pharmacol 2003;191:48–62.
   PubMed Web of Science ®Google Scholar
• Chilcott RP, Dalton CH, Hill I, et al. In vivo skin absorption and distribution of the nerve agent VX (O-ethyl-S-[2(diisopropylamino)ethyl] methylphosphonothioate) in the domestic white pig. Hum Exp Toxicol 2005;24:347–352.
   PubMed Web of Science ®Google Scholar
• Wetherell JR, Armstrong SJ, Read RW, et al. VX penetration following percutaneous poisoning: a dermal microdialysis study in the guinea pig. Toxicol Mech Methods 2008;18:313–321.
   PubMed Web of Science ®Google Scholar
• Joosen MJ, van den Berg RM, de Jong AL, et al. The impact of skin decontamination on the time window for effective treatment of percutaneous VX exposure. Chem Biol Interact 2017;267:48–56.
   PubMed Web of Science ®Google Scholar
• Hamilton MG, Hill I, Conley J, et al. Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: effects of application site and decontamination. Mil Med 2004;169:856–862.
   PubMed Web of Science ®Google Scholar
• Thiermann H, Worek F, Kehe K. Limitations and challenges in treatment of acute chemical warfare agent poisoning. Chem Biol Interact 2013;206:435–443.
   PubMed Web of Science ®Google Scholar
• Bjarnason S, Mikler J, Hill I, et al. Comparison of selected skin decontaminant products and regimens against VX in domestic swine. Hum Exp Toxicol 2008;27:253–261.
   PubMed Web of Science ®Google Scholar
• Braue EH, Smith KH, Doxzon BF, et al. Efficacy studies of reactive skin decontamination lotion, M291 skin decontamination kit, 0.5% bleach, 1% soapy water, and skin exposure reduction paste against chemical warfare agents, part 1: guinea pigs challenged with VX. Cutaneous Ocular Toxicol 2011;30:15–28.
   PubMed Web of Science ®Google Scholar
• Taysse L, Daulon S, Delamanche S, et al. Skin decontamination of mustards and organophosphates: comparative efficiency of RSDL and Fuller’s earth in domestic swine. Hum Exp Toxicol 2007;26:135–141.
   PubMed Web of Science ®Google Scholar
• Thors L, Koch M, Wigenstam E, et al. Comparison of skin decontamination efficacy of commercial decontamination products following exposure to VX on human skin. Chem Biol Interact 2017;273:82–89.
   PubMed Web of Science ®Google Scholar
• Thors L, Wigenstam E, Qvarnström J, et al. Improved skin decontamination efficacy for the nerve agent VX. Chem Biol Interact 2020;325:109135.
   PubMed Web of Science ®Google Scholar
• Joosen MJ, van der Schans MJ, Kuijpers WC, et al. Timing of decontamination and treatment in case of percutaneous VX poisoning: a mini review. Chem Biol Interact 2013;203:149–153.
   PubMed Web of Science ®Google Scholar
• Elsinghorst PW, Worek F, Koller M. Detoxification of organophosphorus pesticides and nerve agents through RSDL: efficacy evaluation by (31)P NMR spectroscopy. Toxicol Lett 2015;233:207–213.
   PubMed Web of Science ®Google Scholar
• Moody RP, Maibach HI. Skin decontamination: importance of the wash-in effect. Food Chem Toxicol 2006;44:1783–1788.
   PubMed Web of Science ®Google Scholar
• Cordery SF, Pensado A, Chiu WS, et al. Topical bioavailability of diclofenac from locally-acting, dermatological formulations. Int J Pharm 2017;529:55–64.
   PubMed Web of Science ®Google Scholar
• Escobar-Chávez JJ, Merino-Sanjuán V, López-Cervantes M, et al. The tape-stripping technique as a method for drug quantification in skin. J Pharm Pharm Sci 2008;11:104–130.
   PubMed Web of Science ®Google Scholar
• Fantini A, Demurtas A, Nicoli S, et al. In vitro skin retention of crisaborole after topical application. Pharmaceutics 2020;12:491.
   Web of Science ®Google Scholar
• Paterson DA, Hallier J, Jenkins E, et al. Is the skin absorption of hydrocortisone modified by the variability in dosing topical products? Pharmaceutics 2018;10:9.
   Web of Science ®Google Scholar
• Cao Y, Hui X, Elmahdy A, et al. In vitro human skin permeation and decontamination of diisopropyl methylphosphonate (DIMP) using dermal decontamination gel (DDGel) and reactive skin decontamination lotion (RSDL) at different timepoints. Toxicol Lett 2018;299:118–123.
   PubMed Web of Science ®Google Scholar
• Cao Y, Hui X, Zhu H, et al. In vitro human skin permeation and decontamination of 2-chloroethyl ethyl sulfide (CEES) using dermal decontamination gel (DDGel) and reactive skin decontamination lotion (RSDL). Toxicol Lett 2018;291:86–91.
   PubMed Web of Science ®Google Scholar
• Lademann J, Jacobi U, Surber C, et al. The tape stripping procedure-evaluation of some critical parameters. Eur J Pharm Biopharm 2009;72:317–323.
   PubMed Web of Science ®Google Scholar
• Dalton C, Graham S, Jenner J. Effect of aqueous dilution on the absorption of the nerve agent VX through skin in vitro. Toxicol in Vitro 2018;53:121–125.
   PubMed Web of Science ®Google Scholar
• Dalton C, Graham S, Jenner J. Effect of exposure area on nerve agent absorption through skin in vitro. Toxicol in Vitro 2015;30:454–461.
   PubMed Web of Science ®Google Scholar
• Rolland P, Bolzinger MA, Cruz C, et al. Human scalp permeability to the chemical warfare agent VX. Toxicol in Vitro 2011;25:1974–1980.
   PubMed Web of Science ®Google Scholar
• Rolland P, Bolzinger MA, Cruz C, et al. Hairy skin exposure to VX in vitro: effectiveness of delayed decontamination. Toxicol in Vitro 2013;27:358–366.
   PubMed Web of Science ®Google Scholar
• Salerno A, Bolzinger MA, Rolland P, et al. Pickering emulsions for skin decontamination. Toxicol in Vitro 2016;34:45–54.
   PubMed Web of Science ®Google Scholar
• WMA. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Med Assoc 2013;310:2191–2194.
   PubMed Web of Science ®Google Scholar
• John M, Ely EW, Halfkann D, et al. Acetylcholinesterase and butyrylcholinesterase in cardiosurgical patients with postoperative delirium. J Intensive Care 2017;5:29.
   PubMed Web of Science ®Google Scholar
• Wenzl T, Haedrich J, Schaechtele A, et al. Guidance document on the estimation of LOD and LOQ for measurements in the field of contaminants in feed and food. Luxembourg, Luxembourg: European Commission; 2016. JRC Technical Reports: EUR 28099 EN2016.
   Google Scholar
• Timperley CM, Abdollahi M, Al-Amri AS, et al. Advice on assistance and protection from the scientific advisory board of the organisation for the prohibition of chemical weapons: part 2. On preventing and treating health effects from acute, prolonged, and repeated nerve agent exposure, and the identification of medical countermeasures able to reduce or eliminate the longer term health effects of nerve agents. Toxicology 2019;413:13–23.
   PubMed Web of Science ®Google Scholar
• Timperley CM, Forman JE, Abdollahi M, et al. Advice on assistance and protection provided by the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons: part 1. On medical care and treatment of injuries from nerve agents. Toxicology 2019;415:56–69.
   PubMed Web of Science ®Google Scholar
• Joosen MJ, van der Schans MJ, van Helden HP. Percutaneous exposure to VX: clinical signs, effects on brain acetylcholine levels and EEG. Neurochem Res 2008;33:308–317.
   PubMed Web of Science ®Google Scholar
• Nozaki H, Aikawa N, Fujishima S, et al. A case of VX poisoning and the difference from sarin. Lancet 1995;346:698–699.
   PubMed Web of Science ®Google Scholar
• Misik J, Pavlikova R, Josse D, et al. In vitro skin permeation and decontamination of the organophosphorus pesticide paraoxon under various physical conditions-evidence for a wash-in effect. Toxicol Mech Methods 2012;22:520–525.
   PubMed Web of Science ®Google Scholar
• Zhu H, Jung EC, Phuong C, et al. Effects of soap-water wash on human epidermal penetration. J Appl Toxicol 2016;36:1526.
   PubMed Web of Science ®Google Scholar
• Matar H, Guerreiro A, Piletsky SA, et al. Preliminary evaluation of military, commercial and novel skin decontamination products against a chemical warfare agent simulant (methyl salicylate). Cutan Ocul Toxicol 2016;35:137–144.
   PubMed Web of Science ®Google Scholar
• Thors L, Koch B, Koch M, et al. In vitro human skin penetration model for organophosphorus compounds with different physicochemical properties. Toxicol in Vitro 2016;32:198–204.
   PubMed Web of Science ®Google Scholar
• Czerwinski SE, Skvorak JP, Maxwell DM, et al. Effect of octanol: water partition coefficients of organophosphorus compounds on biodistribution and percutaneous toxicity. J Biochem Mol Toxicol 2006;20:241–246.
   PubMed Web of Science ®Google Scholar
• Munro NB, Talmage SS, Griffin GD, et al. The sources, fate, and toxicity of chemical warfare agent degradation products. Environ Health Perspect 1999;107:933–974.
   PubMed Web of Science ®Google Scholar
• Read R, Black R, Hakala U, et al. Recommended operating procedures for analysis in the verification of chemical disarment. Vol. 22. Helsinki, Finland: University of Helsinki; 2017.
   Google Scholar
• Tsuchihashi H, Katagi M, Nishikawa M, et al. Identification of metabolites of nerve agent VX in serum collected from a victim. J Anal Toxicol 1998;22:383–388.
   PubMed Web of Science ®Google Scholar
• Blaauboer BJ. Biokinetic modeling and in vitro-in vivo extrapolations. J Toxicol Environ Health B Crit Rev 2010;13:242–252.
   PubMed Web of Science ®Google Scholar
• Wetmore BA. Quantitative in vitro-to-in vivo extrapolation in a high-throughput environment. Toxicology 2015;332:94–101.
   PubMed Web of Science ®Google Scholar
• Schwartz MD, Hurst CG, Kirk MA, et al. Reactive skin decontamination lotion (RSDL) for the decontamination of chemical warfare agent (CWA) dermal exposure. Curr Pharm Biotechnol 2012;13:1971–1979.
   PubMed Web of Science ®Google Scholar
• Misik J, Pavlik M, Novotny L, et al. In vivo decontamination of the nerve agent VX using the domestic swine model. Clin Toxicol 2012;50:807–811.
   PubMed Web of Science ®Google Scholar